Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
| ▸ | HNF4A | P41235 | 1/20 | 0.53 |
| ▸ | BCAT2 | O15382 | 1/20 | 0.52 |
| ▸ | DHODH | Q02127 | 1/20 | 0.51 |
| ▸ | CHRNB2 | P17787 | 3/20 | 0.50 |
| ▸ | CHRNB4 | P30926 | 3/20 | 0.50 |
| ▸ | CHRNA3 | P32297 | 3/20 | 0.50 |
| ▸ | CHRNA4 | P43681 | 3/20 | 0.50 |
| ▸ | LTB4R2 | Q9NPC1 | 2/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | FABP3 | P05413 | 1/20 | 0.49 |
| ▸ | FABP4 | P15090 | 1/20 | 0.49 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyridine SCHEMBL9227339 | 0.90 | ALDH1A1 (0.58) | ALDH1A1SMN1; SMN2NPC1RAB9AHNF4A | |
| SCHEMBL29105027 | 0.88 | ALDH1A1 (0.49) | ALDH1A1SMN1; SMN2NPC1RAB9AHNF4A | |
| Phthalic Acid SCHEMBL1649174 | 0.85 | ALDH1A1 (0.64) | ALDH1A1SMN1; SMN2NPC1RAB9ADHODH | |
| Benzene SCHEMBL28480917 | 0.85 | HNF4A (0.69) | ALDH1A1SMN1; SMN2NPC1RAB9AHNF4A | |
| SCHEMBL133057 | 0.85 | HNF4A (0.69) | ALDH1A1SMN1; SMN2NPC1RAB9AHNF4A | |
| Benzene SCHEMBL1403559 | 0.85 | HNF4A (0.69) | ALDH1A1SMN1; SMN2NPC1RAB9AHNF4A | |
| SCHEMBL26624744 | 0.85 | HNF4A (0.69) | ALDH1A1SMN1; SMN2NPC1RAB9AHNF4A | |
| SCHEMBL18759613 | 0.85 | HNF4A (0.63) | ALDH1A1SMN1; SMN2NPC1RAB9AHNF4A | |
| SCHEMBL30292805 | 0.85 | HNF4A (0.63) | ALDH1A1SMN1; SMN2NPC1RAB9AHNF4A | |
| SCHEMBL38663696 | 0.85 | DHODH (0.54) | ALDH1A1SMN1; SMN2NPC1RAB9ADHODH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117696012-A | Metal organic framework material and preparation method and application thereof | 浙江大学 | 2024-03-15 | — | — | CN | claimed |
| CN-115304996-B | Water-based environment-friendly high-performance UV surface treating agent | 广东远东高分子科技有限公司 | 2022-12-20 | — | — | CN | claimed |
| CN-115304996-A | Water-based environment-friendly high-performance UV surface treating agent | 广东远东高分子科技有限公司 | 2022-11-08 | — | — | CN | claimed |
| CN-110270233-B | Metal organic framework nanosheet mixed matrix membrane and preparation method and application thereof | 浙江工业大学 | 2021-11-23 | — | — | CN | claimed |
| CN-113185497-A | Synthetic method of 3, 6-di (4-pyridyl) -9- (4-pyridylphenyl) -9H-carbazole | 运城学院 | 2021-07-30 | — | — | CN | claimed |
| CN-111924887-A | Preparation method of micron cobalt disulfide composite material | 北京科技大学 | 2020-11-13 | — | — | CN | claimed |
| CN-109796783-B | Zinc porphyrin supermolecule dye sensitizer and preparation method and application thereof | 江苏理工学院 | 2020-10-30 | — | — | CN | claimed |
| CN-108299478-B | Cadmium-based metal organic framework material and preparation method and application thereof | 华南师范大学 | 2020-03-24 | — | — | CN | claimed |
| US-12297209-B2 | Benzodiazepine derivatives as RSV inhibitors | ENANTA PHARMACEUTICALS, INC. (US) | 2025-05-13 | — | — | US | disclosed |
| US-12268694-B2 | Combination pharmaceutical agents as RSV inhibitors | ENANTA PHARMACEUTICALS, INC. (US) | 2025-04-08 | — | — | US | disclosed |
| CN-118271516-B | Water-resistant room temperature phosphorescence gradient reinforced material and preparation method thereof | 广东工业大学 | 2025-02-11 | — | — | CN | disclosed |
| US-20240360155-A1 | Benzodiazepine Derivatives as RSV Inhibitors | ENANTA PHARM INC (US) | 2024-10-31 | — | — | US | disclosed |
| CN-118271516-A | Water-resistant room temperature phosphorescence gradient reinforced material and preparation method thereof | 广东工业大学 | 2024-07-02 | — | — | CN | disclosed |
| CN-118206529-A | Dihydrobenzimidazolone | C4医药公司 | 2024-06-18 | — | — | CN | disclosed |
| EP-0575425-B1 | USE OF OXAZOLO- 2,3-a]ISOINDOLE AND IMIDAZO 2,1-a]ISOINDOLE DERIVATIVES AS ANTIVIRAL DRUGS, AND NEW OXAZOLO 2,3-a]ISOINDOLE DERIVATIVES | BOEHRINGER MANNHEIM GMBH (DE) | 1995-10-11 | — | — | EP | disclosed |
| EP-0569457-B1 | USE OF THIAZOLO-[2,3-A]ISOINDOLE DERIVATIVES AS ANTIVIRAL MEDICAMENTS AND NOVEL THIAZOLO- [2,3-A]ISOINDOLE DERIVATIVES | BOEHRINGER MANNHEIM GMBH (DE) | 1995-06-14 | — | — | EP | disclosed |
| EP-0575425-A1 | USE OF OXAZOLO- 2,3-a]ISOINDOLE AND IMIDAZO 2,1-a]ISOINDOLE DERIVATIVES AS ANTIVIRAL DRUGS, AND NEW OXAZOLO 2,3-a]ISOINDOLE DERIVATIVES. | BOEHRINGER MANNHEIM GMBH (DE) | 1993-12-29 | — | — | EP | disclosed |
| EP-0569457-A1 | USE OF THIAZOLO- 2,3-A]ISOINDOLE DERIVATIVES AS ANTIVIRAL MEDICAMENTS AND NOVEL THIAZOLO- 2,3-A]ISOINDOLE DERIVATIVES. | BOEHRINGER MANNHEIM GMBH (DE) | 1993-11-18 | — | — | EP | disclosed |
| WO-1992016207-A1 | USE OF OXAZOLO-[2,3-a]ISOINDOLE AND IMIDAZO[2,1-a]ISOINDOLE DERIVATIVES AS ANTIVIRAL DRUGS, AND NEW OXAZOLO[2,3-a]ISOINDOLE DERIVATIVES | BOEHRINGER MANNHEIM GMBH (DE) | 1992-10-01 | — | — | WO | disclosed |
| WO-1992013863-A1 | USE OF THIAZOLO-[2,3-A]ISOINDOLE DERIVATIVES AS ANTIVIRAL MEDICAMENTS AND NOVEL THIAZOLO-[2,3-A]ISOINDOLE DERIVATIVES | BOEHRINGER MANNHEIM GMBH (DE) | 1992-08-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240360155-A1 | Benzodiazepine Derivatives as RSV Inhibitors | GABRA5, GABRA1, GABBR2 | ALDH1A1 621/4885SMN1; SMN2 627/4885NPC1 224/4885 |
| US-12297209-B2 | Benzodiazepine derivatives as RSV inhibitors | GABRA5, GABRA1, GABBR2 | ALDH1A1 621/4885SMN1; SMN2 627/4885NPC1 224/4885 |
| US-12268694-B2 | Combination pharmaceutical agents as RSV inhibitors | ACE, ACE2, SPCS3 | ALDH1A1 4172/4885SMN1; SMN2 591/4885NPC1 399/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.